This website uses cookies. By continuing you are agreeing to our privacy policy.

American Lung Association Researcher at Helm of Protein Discovery that Constrains COVID-19

Breakthrough Could Inform Coronavirus Treatment Strategies

covid 19 research

COVID-19 is currently the top story worldwide. Other events of the new year seemingly pale in comparison to how this evolving health crisis – now upgraded to a pandemic by the World Health Organization (WHO) – continues to unapologetically consume our daily lives.

So, in this spirit, we exchanged germ-free elbow bumps upon learning that one of our researchers, John Schoggins, Ph.D., made an exciting medical discovery in early March. An associate professor of microbiology at UT Southwestern Medical Center in Dallas, Texas, Dr. Schoggins and his international collaborators (Charles Rice, Ph.D., at The Rockefeller University in New York and Volker Thiel, Ph.D., at University of Bern in Switzerland) are credited with identifying LY6E, a naturally occurring protein that has been shown to inhibit coronavirus infection. Their findings are detailed in a pre-print article, entitled “LY6E Impairs Coronavirus Fusion and Confers Immune Control of Viral Disease.”

“My lab has a longstanding history researching how cells defend themselves from viral infection. This particular protein, LY6E, demonstrates the ability to block the COVID-19 virus and other coronaviruses like SARS and MERS from fusing to the cells, thus significantly reducing the probability of infection when tested in vitro [outside living organism]. It also helps the immune system control coronavirus disease in vivo [within living organism],” explained Dr. Schoggins to the Lung Association.

Dr. Schoggins received the Lung Association’s Innovation Award in 2019-2020, which aims to match the brightest minds with the best science, in support and recognition of his pioneering project, “New Avenue for Keeping Influenza in Check.” Through this project, which set out to investigate how macrophages [large white blood cells] affect the influenza virus, the team ultimately landed on LY6E and determined it plays a key role in the primary immune response defending against coronavirus. Quite an opportune outcome during an ongoing global race to curb the fast-paced spread of COVID-19.

Now that LY6E has been detected and examined, they plan to expand their inquiry to see whether it can be translated into treatment options. “We’re thinking about ways to mimic LY6E in the hopes of developing a complementary small molecule or peptide drug target, along the lines of a fusion inhibitor,” Dr. Schoggins added. “The team is appreciative of organizations such as the American Lung Association for taking chances on cutting-edge research such as ours.”

We’ll keep you updated on next steps of Dr. Schoggins’ study, but in the meantime, we’re proud that our Research Team is hard at work on timely and impactful research! Continue to follow the American Lung Association on the social platform of your choice for all your lung health and respiratory news.

----
Related Topics: Health & Wellness, Research,


Leave a comment

You must be logged in to leave a comment. If you are new to the site, complete our quick Registration Form to create a User Name and Password.

Sign-In

Comments


Submitted by Rampart at: March 18, 2020
I Pray you research will help solve these diseases. Just like Dr Salk did in the 50s. God Bless.
Submitted by gibbers52 at: March 17, 2020
I am so very impressed and excited to see this research and its findings. Keep going! I have decided to donate monthly/forever due to this research
Red button with telephone
Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
Red button of two hand prints
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.

Button of turquoise LUNG FORCE swirl
What is LUNG FORCE?

LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved

 

Breathe Easy

Give today and your tax-deductible gift will go TWICE as far for everyone who struggles to breathe.